These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


401 related items for PubMed ID: 8828760

  • 1. Recommendations for the development of vaginal microbicides. International Working Group on Vaginal Microbicides.
    AIDS; 1996 Jul; 10(8):1-6. PubMed ID: 8828760
    [Abstract] [Full Text] [Related]

  • 2. Microbicidal spermicide or spermicidal microbicide?
    Gupta G.
    Eur J Contracept Reprod Health Care; 2005 Dec; 10(4):212-8. PubMed ID: 16448947
    [Abstract] [Full Text] [Related]

  • 3. Women's interest in vaginal microbicides.
    Darroch JE, Frost JJ.
    Fam Plann Perspect; 1999 Dec; 31(1):16-23. PubMed ID: 10029928
    [Abstract] [Full Text] [Related]

  • 4. Microbicides: putting women in control.
    Forbes A.
    WORLD; 1998 Sep; (89):4-5. PubMed ID: 11365770
    [Abstract] [Full Text] [Related]

  • 5. Microbicides to prevent HIV transmission: overcoming obstacles to chemical barrier protection.
    Dhawan D, Mayer KH.
    J Infect Dis; 2006 Jan 01; 193(1):36-44. PubMed ID: 16323129
    [Abstract] [Full Text] [Related]

  • 6. A summary of preclinical topical microbicide vaginal safety and chlamydial efficacy evaluations in a pigtailed macaque model.
    Patton DL, Cosgrove Sweeney YT, Paul KJ.
    Sex Transm Dis; 2008 Oct 01; 35(10):889-97. PubMed ID: 18607310
    [Abstract] [Full Text] [Related]

  • 7. Topical microbicides: the time has come.
    Dhawan D, Keller M, Klotman ME.
    AIDS Read; 2006 Mar 01; 16(3):144-8, 155-8, 161; discussion 148, 156-7. PubMed ID: 16538955
    [Abstract] [Full Text] [Related]

  • 8. Clinical development of microbicides for the prevention of HIV infection.
    D'Cruz OJ, Uckun FM.
    Curr Pharm Des; 2004 Mar 01; 10(3):315-36. PubMed ID: 14754390
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Acceptability of a non-woven device for vaginal drug delivery of microbicides or other active agents.
    Joanis CL, Hart CW.
    AIDS Behav; 2010 Jun 01; 14(3):600-6. PubMed ID: 20049522
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Desired qualities and hypothetical contextual use of vaginal microbicides in a diverse sample of US women.
    Olsen ML, Cwiak CA, Koudelka C, Jensen JT.
    Contraception; 2007 Oct 01; 76(4):314-8. PubMed ID: 17900444
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. A human colorectal explant culture to evaluate topical microbicides for the prevention of HIV infection.
    Abner SR, Guenthner PC, Guarner J, Hancock KA, Cummins JE, Fink A, Gilmore GT, Staley C, Ward A, Ali O, Binderow S, Cohen S, Grohskopf LA, Paxton L, Hart CE, Dezzutti CS.
    J Infect Dis; 2005 Nov 01; 192(9):1545-56. PubMed ID: 16206069
    [Abstract] [Full Text] [Related]

  • 16. Microbicides: a new frontier in HIV prevention.
    McGowan I.
    Biologicals; 2006 Dec 01; 34(4):241-55. PubMed ID: 17097303
    [Abstract] [Full Text] [Related]

  • 17. Microbicides: a new approach to preventing HIV and other sexually transmitted infections.
    Stone A.
    Nat Rev Drug Discov; 2002 Dec 01; 1(12):977-85. PubMed ID: 12461519
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 21.